Literature DB >> 26047108

Novel GABA receptor pesticide targets.

John E Casida1, Kathleen A Durkin2.   

Abstract

The γ-aminobutyric acid (GABA) receptor has four distinct but overlapping and coupled targets of pesticide action importantly associated with little or no cross-resistance. The target sites are differentiated by binding assays with specific radioligands, resistant strains, site-directed mutagenesis and molecular modeling. Three of the targets are for non-competitive antagonists (NCAs) or channel blockers of widely varied chemotypes. The target of the first generation (20th century) NCAs differs between the larger or elongated compounds (NCA-IA) including many important insecticides of the past (cyclodienes and polychlorocycloalkanes) or present (fiproles) and the smaller or compact compounds (NCA-IB) highly toxic to mammals and known as cage convulsants, rodenticides or chemical threat agents. The target of greatest current interest is designated NCA-II for the second generation (21st century) of NCAs consisting for now of isoxazolines and meta-diamides. This new and uniquely different NCA-II site apparently differs enough between insects and mammals to confer selective toxicity. The fourth target is the avermectin site (AVE) for allosteric modulators of the chloride channel. NCA pesticides vary in molecular surface area and solvent accessible volume relative to avermectin with NCA-IBs at 20-22%, NCA-IAs at 40-45% and NCA-IIs at 57-60%. The same type of relationship relative to ligand-docked length is 27-43% for NCA-IBs, 63-71% for NCA-IAs and 85-105% for NCA-IIs. The four targets are compared by molecular modeling for the Drosophila melanogaster GABA-R. The principal sites of interaction are proposed to be: pore V1' and A2' for NCA-IB compounds; pore A2', L6' and T9' for NCA-IA compounds; pore T9' to S15' in proximity to M1/M3 subunit interface (or alternatively an interstitial site) for NCA-II compounds; and M1/M3, M2 interfaces for AVE. Understanding the relationships of these four binding sites is important in resistance management and in the discovery and use of safe and effective pest control agents.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GABA receptor; Insecticide; Isoxazoline; Meta-diamide; Radioligand

Mesh:

Substances:

Year:  2014        PMID: 26047108     DOI: 10.1016/j.pestbp.2014.11.006

Source DB:  PubMed          Journal:  Pestic Biochem Physiol        ISSN: 0048-3575            Impact factor:   3.963


  21 in total

1.  Rapid Throughput Analysis of GABAA Receptor Subtype Modulators and Blockers Using DiSBAC1(3) Membrane Potential Red Dye.

Authors:  Atefeh Mousavi Nik; Brandon Pressly; Vikrant Singh; Shane Antrobus; Susan Hulsizer; Michael A Rogawski; Heike Wulff; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2017-04-20       Impact factor: 4.436

2.  Abamectin treatment affects glutamate decarboxylase expression and induces higher GABA levels in the citrus red mite, Panonychus citri.

Authors:  Wei Dou; Wen-Kai Xia; Jin-Zhi Niu; Jin-Jun Wang
Journal:  Exp Appl Acarol       Date:  2017-06-27       Impact factor: 2.132

3.  Heterogeneous expression of GABA receptor-like subunits LCCH3 and GRD reveals functional diversity of GABA receptors in the honeybee Apis mellifera.

Authors:  Christopher Henry; Thierry Cens; Pierre Charnet; Catherine Cohen-Solal; Claude Collet; Juliette van-Dijk; Janique Guiramand; Marie-Céleste de Jésus-Ferreira; Claudine Menard; Nawfel Mokrane; Julien Roussel; Jean-Baptiste Thibault; Michel Vignes; Matthieu Rousset
Journal:  Br J Pharmacol       Date:  2020-06-29       Impact factor: 8.739

4.  Multiple combinations of RDL subunits diversify the repertoire of GABA receptors in the honey bee parasite Varroa destructor.

Authors:  Claudine Ménard; Mathilde Folacci; Lorène Brunello; Mercedes Charreton; Claude Collet; Rosanna Mary; Matthieu Rousset; Jean-Baptiste Thibaud; Michel Vignes; Pierre Charnet; Thierry Cens
Journal:  J Biol Chem       Date:  2018-10-17       Impact factor: 5.157

5.  Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases.

Authors:  Marie Miglianico; Maarten Eldering; Hannah Slater; Neil Ferguson; Pauline Ambrose; Rosemary S Lees; Karin M J Koolen; Katerina Pruzinova; Magdalena Jancarova; Petr Volf; Constantianus J M Koenraadt; Hans-Peter Duerr; Graham Trevitt; Baiyuan Yang; Arnab K Chatterjee; John Wisler; Angelika Sturm; Teun Bousema; Robert W Sauerwein; Peter G Schultz; Matthew S Tremblay; Koen J Dechering
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

6.  Synergistic and compensatory effects of two point mutations conferring target-site resistance to fipronil in the insect GABA receptor RDL.

Authors:  Yixi Zhang; Xiangkun Meng; Yuanxue Yang; Hong Li; Xin Wang; Baojun Yang; Jianhua Zhang; Chunrui Li; Neil S Millar; Zewen Liu
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

7.  RDL mutations predict multiple insecticide resistance in Anopheles sinensis in Guangxi, China.

Authors:  Chan Yang; Zushi Huang; Mei Li; Xiangyang Feng; Xinghui Qiu
Journal:  Malar J       Date:  2017-11-28       Impact factor: 2.979

8.  Permethrin resistance in Aedes aegypti: Genomic variants that confer knockdown resistance, recovery, and death.

Authors:  Karla Saavedra-Rodriguez; Corey L Campbell; Saul Lozano; Patricia Penilla-Navarro; Alma Lopez-Solis; Francisco Solis-Santoyo; Americo D Rodriguez; Rushika Perera; William C Black Iv
Journal:  PLoS Genet       Date:  2021-06-17       Impact factor: 5.917

9.  Transcriptome Analysis of the Central and Peripheral Nervous Systems of the Spider Cupiennius salei Reveals Multiple Putative Cys-Loop Ligand Gated Ion Channel Subunits and an Acetylcholine Binding Protein.

Authors:  Päivi H Torkkeli; Hongxia Liu; Andrew S French
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

10.  Preparation, Characterization, and Insecticidal Activity of Avermectin-Grafted-Carboxymethyl Chitosan.

Authors:  Yan Li; Yukun Qin; Song Liu; Ronge Xing; Huahua Yu; Kecheng Li; Pengcheng Li
Journal:  Biomed Res Int       Date:  2016-04-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.